- Aurora kinase A as a possible marker for endocrine resistance in early estrogen receptor positive breast cancer
Anne E. Lykkesfeldt et al, 2018, Acta Oncologica CrossRef - Decreased ER dependency after acquired resistance to CDK4/6 inhibitors
Masafumi Iida et al, 2020, Breast Cancer CrossRef - Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers
Marianne Hauglid Flågeng et al, 2017, The Journal of Steroid Biochemistry and Molecular Biology CrossRef - HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells
Belinda J. Petri et al, 2021, Cancer Letters CrossRef - PEGylated Protamine Letrozole Nanoparticles: A Promising Strategy to Combat Human Breast Cancer via MCF-7 Cell Lines
Muhammad Tafhim Khan et al, 2022, BioMed Research International CrossRef - Natural products as drug candidates for breast cancer (Review)
Nitin Telang, 2023, Oncology Letters CrossRef - Aurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells
Stine Hole et al, 2015, Breast Cancer Research and Treatment CrossRef - Natural phytochemicals as testable therapeutic alternatives for HER‑2‑enriched breast cancer (Review)
Nitin Telang, 2020, World Academy of Sciences Journal CrossRef - Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer
Muriel Lainé et al, 2024, Breast Cancer Research CrossRef - Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines
Srinivas Burra et al, 2017, Bioorganic & Medicinal Chemistry Letters CrossRef - Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients
Karina G. Thomsen et al, 2015, Breast Cancer Research and Treatment CrossRef - Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
Derek F. Amanatullah et al, 2017, Breast Cancer Research CrossRef - Partitioning of cancer therapeutics in nuclear condensates
Isaac A. Klein et al, 2020, Science CrossRef - MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
Sanne Løkkegaard et al, 2021, npj Breast Cancer CrossRef - Acquired resistance to aromatase inhibitors: where we stand!
Tiago Vieira Augusto et al, 2018, Endocrine-Related Cancer CrossRef - The Divergent Effects of Ovarian Steroid Hormones in the MCF-7 Model for Luminal A Breast Cancer: Mechanistic Leads for Therapy
Nitin T. Telang, 2022, International Journal of Molecular Sciences CrossRef - Modelling the procoagulatory effect of Anastrozole relative to ERα and ERβ expression in breast cancer cells
Kyrtania Pather et al, 2022, Journal of Thrombosis and Thrombolysis CrossRef - Growth inhibitory efficacy and anti‑aromatase activity of Tabebuia avellanedae in a model for post‑menopausal Luminal A breast cancer
Nitin Telang et al, 2019, Biomedical Reports CrossRef - Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
Abeer J. Al-Qasem et al, 2022, npj Precision Oncology CrossRef